Texas § 441.0101 RIGHT TO CORRECT.

Texas Statutes

§ 441.0101 — RIGHT TO CORRECT.

Texas § 441.0101

Code HSHealth and Safety Code

This text of Texas § 441.0101 (RIGHT TO CORRECT.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Health and Safety Code Code Ann. § 441.0101 (2026).

Text

Sec. 441.0101. RIGHT TO CORRECT.

(a)If the department determines that a pharmaceutical drug manufacturer failed to submit a report or fee required under, or failed to submit the report or fee in the manner prescribed by, Subchapter B and the rules adopted under this chapter, the department shall provide written notice of the failure to the manufacturer.

(b)On receipt of notice described by Subsection (a), a pharmaceutical drug manufacturer shall submit, as applicable:

(1)a report that:

(A)complies with Subchapter B and rules adopted under this chapter; and

(B)addresses the issues raised in the notice; or

(2)the fee required by Section 441.0055 .

(c)The department may not assess an administrative penalty under Section 441.0102 against a pharmaceutical drug manufacturer that submits t

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 441.0101. RIGHT TO CORRECT. (a) If the department determines that a pharmaceutical drug manufacturer failed to submit a report or fee required under, or failed to submit the report or fee in the manner prescribed by, Subchapter B and the rules adopted under this chapter, the department shall provide written notice of the failure to the manufacturer.
(b) On receipt of notice described by Subsection (a), a pharmaceutical drug manufacturer shall submit, as applicable:
(1) a report that:
(A) complies with Subchapter B and rules adopted under this chapter; and
(B) addresses the issues raised in the notice; or
(2) the fee required by Section 441.0055 .
(c) The department may not assess an administrative penalty under Section 441.0102 against a pharmaceutical drug manufacturer that submits to the department the required report or fee, as applicable, on or before the 45th day after the date the manufacturer receives notice under Subsection (a).